NCT05037708

Brief Summary

Lymphedema related to breast cancer is one of the main complications after breast cancer treatment. Manual lymphatic drainage appears as a technique which could be applied in the treatment of lymphedema along with other techniques. The aim of this study is to analyze the effects of a physiotherapy program based on manual lymphatic drainage on the treatment of lymphedema after breast cancer, during the stabilization or maintenance phase of complex decongestant therapy. Therefore, a randomized, blinded, crossover clinical trial is suggested to assess the effect of an intensive physiotherapy intervention on the treatment of lymphedema in its maintenance phase, in comparison with a control group without physiotherapy treatment. The cytometry, displaced water volume, thickness of the lymphedema with ultrasound, dynamometry and sensation of heaviness, pain and tension of the upper limb will be evaluated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 19, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 8, 2021

Completed
6 months until next milestone

Study Start

First participant enrolled

March 1, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 27, 2022

Completed
Last Updated

April 6, 2023

Status Verified

April 1, 2023

Enrollment Period

4 months

First QC Date

July 19, 2021

Last Update Submit

April 4, 2023

Conditions

Keywords

Lymphedema of Upper LimbBreast NeoplasmsPhysical Therapy Modalities

Outcome Measures

Primary Outcomes (12)

  • circometry

    measurement of upper limb perimeters

    1 day

  • circometry

    measurement of upper limb perimeters

    1 month

  • circometry

    measurement of upper limb perimeters

    3 month

  • circometry

    measurement of upper limb perimeters

    4 month

  • Volumetry by water displacement

    weight of water extravasated when introducing the upper limb into a container with water

    1 day

  • Volumetry by water displacement

    weight of water extravasated when introducing the upper limb into a container with water

    1 month

  • Volumetry by water displacement

    weight of water extravasated when introducing the upper limb into a container with water

    3 month

  • Volumetry by water displacement

    weight of water extravasated when introducing the upper limb into a container with water

    4 month

  • Measurement of edema thickness by ultrasound

    measurement of subcutaneous tissue thickness

    1 day

  • Measurement of edema thickness by ultrasound

    measurement of subcutaneous tissue thickness

    1 month

  • Measurement of edema thickness by ultrasound

    measurement of subcutaneous tissue thickness

    3 month

  • Measurement of edema thickness by ultrasound

    measurement of subcutaneous tissue thickness

    4 month

Secondary Outcomes (16)

  • Assessment of the sensation of heaviness

    1 day

  • Assessment of the sensation of heaviness

    1 month

  • Assessment of the sensation of heaviness

    3 month

  • Assessment of the sensation of heaviness

    4 month

  • Assessment of the sensation of pain

    1 day

  • +11 more secondary outcomes

Study Arms (2)

Group 1

EXPERIMENTAL

Group 1 receives treatment A for 4 weeks. Afterwards, a period of washing or bleaching should be allowed in order to be sure that the effects of the intervention have disappeared. This period will last 2 months during which the usual treatment for LGA patients will be carried out, which consists of 2 monthly physiotherapy sessions, in this way it is intended that the subjects are in the initial state (as before the start of the first intervention). After this washout period, treatment B was applied to group 1.

Procedure: Manual lymphatic drainage

Group 2

ACTIVE COMPARATOR

Group 2 receives treatment B for 4 weeks. Afterwards, a period of washing or bleaching should be allowed in order to be sure that the effects of the intervention have disappeared. This period will last 2 months during which the usual treatment for LGA patients will be carried out, which consists of 2 monthly physiotherapy sessions, in this way it is intended that the subjects are in the initial state (as before the start of the first intervention). After this washout period, treatment A was applied to group 2 .

Procedure: Manual lymphatic drainage

Interventions

Subjects are randomly assigned to group 1. Group 1 receives treatment A\* for 4 weeks. Afterwards, a period of washing or bleaching should be allowed in order to be sure that the effects of the intervention have disappeared. This period will last 2 months during which the usual treatment for LGA patients will be carried out, which consists of 2 monthly physiotherapy sessions, in this way it is intended that the subjects are in the initial state (as before the start of the first intervention). After this washout period, treatment B\*\* was applied to group 1 for 4 weeks. \*Treatment A consists of manual lymphatic drainage. \*\*Treatment B consists of no treatment

Group 1

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Women included in the lymphedema treatment maintenance program through the Galician Lymphedema Association
  • Women with secondary unilateral lymphedema after breast cancer

You may not qualify if:

  • Women undergoing chemotherapy or radiotherapy treatment.
  • Severe systemic or neurological disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Physiotherapy

Pontevedra, 36005, Spain

Location

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Manual Lymphatic Drainage

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

MassageTherapy, Soft TissueMusculoskeletal ManipulationsComplementary TherapiesTherapeuticsDrainagePhysical Therapy ModalitiesRehabilitation

Study Officials

  • Eva M Lantarón_Caeiro, Dra

    Physiotherapy Group (FS1) - Faculty of Physiotherapy -University of Vigo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Therefore, a randomized, blinded, crossover clinical trial is suggested to assess the effect of an intensive physiotherapy intervention on the treatment of lymphedema in its maintenance phase, in comparison with a control group without physiotherapy treatment.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 19, 2021

First Posted

September 8, 2021

Study Start

March 1, 2022

Primary Completion

July 1, 2022

Study Completion

October 27, 2022

Last Updated

April 6, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations